Asfar Azmi, PhD, discusses the tricomplex mechanism of daraxonrasib and its impact on overall survival for patients with pancreatic cancer.
Asfar Azmi, PhD
Advertisement
Articles by Asfar Azmi, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Cardiac Assessment With Atrial Fibrillation and Closing Thoughts
2
FDA Receives BLA for Etentamig in Relapsed/Refractory Multiple Myeloma
3
Cisplatin-Free Pembrolizumab Regimen Misses Primary End Point in SMART-KEY
4
Prior ICI Exposure Linked to Higher Dermatitis Risk With Lirafugratinib in FGFR2-Altered Tumors
5